December 19, 2024
Rose
The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse reactions.
from NYT > Health https://ift.tt/PgsKAl9
December 19, 2024
Rose
Health - The New York Times, NYT > Health
No comments
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment